Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Non-Current Debt (2022 - 2024)

Intelligent Bio Solutions has reported Non-Current Debt over the past 3 years, most recently at $150426.0 for Q1 2024.

  • For Q1 2024, Non-Current Debt fell 68.05% year-over-year to $150426.0; the TTM value through Mar 2024 reached $150426.0, down 68.05%, while the annual FY2023 figure was $402862.0, N/A changed from the prior year.
  • Non-Current Debt for Q1 2024 was $150426.0 at Intelligent Bio Solutions, down from $230969.0 in the prior quarter.
  • Over five years, Non-Current Debt peaked at $507403.0 in Q4 2022 and troughed at $150426.0 in Q1 2024.
  • A 3-year average of $344794.3 and a median of $354548.0 in 2023 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: plummeted 54.48% in 2023 and later crashed 68.05% in 2024.
  • Year by year, Non-Current Debt stood at $507403.0 in 2022, then plummeted by 54.48% to $230969.0 in 2023, then crashed by 34.87% to $150426.0 in 2024.
  • Business Quant data shows Non-Current Debt for INBS at $150426.0 in Q1 2024, $230969.0 in Q4 2023, and $306234.0 in Q3 2023.